Effectiveness of Topical ρ-Kinase Inhibitors in Veterans with Severe Glaucoma on Maximally Tolerated Medical Therapy

1Department of Ophthalmology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California

2Department of Surgery, Veterans Health Administration of Greater Los Angeles, Los Angeles, California

[email protected]

Submitted: April 14, 2022

Accepted: July 3, 2022

Funding/Support: Research to Prevent Blindness.

Conflict of Interest Disclosure: None of the authors have reported a financial conflict of interest.

Study Registration Information: This study was approved by the Institutional Review Board of the Greater Los Angeles VA.

Author Contributions: Conceptualization: SKL, JG; Data Curation: RK, SWH; Formal Analysis: RK, SKL, JG; Investigation: RK, SKL, JG; Methodology: RK, SKL, JG; Project Administration: SKL, JG; Supervision: SKL, JG; Validation: JG; Visualization: RK; Writing – Original Draft: RK; Writing – Review & Editing: RK, SKL, JG.

留言 (0)

沒有登入
gif